Pfizer Inc. Stock Hits Day High with Strong Intraday Performance

Pfizer Inc. has experienced a notable uptick in its stock performance, gaining 3.16% on March 17, 2026. The stock reached an intraday high of USD 27.76, reflecting a positive trend in the company's market activity. Over the past week, Pfizer has outperformed the S&P 500, which saw a decline of 0.96%, while Pfizer's performance was up by 1.07%. In terms of financial health, Pfizer boasts a strong management efficiency, highlighted by a return on capital employed (ROCE) of 16.86%. The company has demonstrated a solid ability to manage its debt, with a low Debt to EBITDA ratio of 2.16 times. Positive results have been reported for the last three consecutive quarters, with a net profit of USD 11,738.38 million, reflecting a growth of 53.8%. Despite underperforming the market over the past year, with a return of 2.26% compared to the S&P 500's 14.11%, Pfizer maintains a high dividend yield of 286.00%, indicating a strong return for shareholders. The stock is currently trading at a discount relative to its peers, suggesting an attractive valuation in the pharmaceuticals and biotechnology sector.